Mature results of a phase II trial of concomitant cisplatin/pelvic radiotherapy for locally advanced squamous cell carcinoma of the cervix

Gynecologic Oncology

Volumn 61, Issue 3, 1996, Pages 416-422

  Fields, Abbie L ^a   Anderson, Patrick S ^a   Goldberg, Gary L ^a   Wadler, Scott ^a   Beitler, Jonathan ^a   Sood, Brij ^a   Runowicz, Carolyn D ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; LORAZEPAM; METOCLOPRAMIDE; RADIOSENSITIZING AGENT; SODIUM CHLORIDE;

ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL PROTOCOL; CLINICAL TRIAL; FEMALE; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION ENTEROPATHY; TREATMENT FAILURE; UTERINE CERVIX CARCINOMA;

EID: 0029888303     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.0166     Document Type: Article

References (42)

1. Montana, G. S., Fowler, W. C., Varia, M. A., et al. Carcinoma of the cervix, stage III: Results of radiation therapy, Cancer 57, 148-154 (1986).
2. Perez, C. A., Camel, H. M., Kuske, R. R., Kao, M. S., Galakatos, A., Hederman, M. A., and Powers, W. E. Radiation therapy alone in the treatment of carcinoma of the uterine cervix: A 20-year experience, Gynecol. Oncol. 23, 127-140 (1986).
3. Jampolis, S., Andras, E. J., and Fletcher, G. H. Analysis of sites and causes of failures of irradiation in invasive squamous cell carcinoma of the intact uterine cervix, Radiology 115, 681-685 (1975).
4. Leibel, S., Bauer, M., Wasserman, T., Marcial, V., Rotman, M., Hornback, N., Cooper, J., Gillespsie, B., Pakuris, E., Conner, N., and Martin-Durbin, L. Radiotherapy with or without misonidaxole for patients with stage IIIB or stage IVA squamous cell carcinoma of the uterine cervix: Preliminary report of a Radiation Therapy Oncology Group randomized trial, Int. J. Radiat. Oncol. Biol. Phys. 13, 541-549 (1987).
5. Brady, L. W., Plenk, H. P., Hanley, J. A., Glassburn, J. R., Kramer, S., and Parker, R. G. Hyperbaric oxygen therapy for carcinoma of the cervix - stages IIB, IIIB, and IVA: Results of a randomized study by the Radiation Therapy Oncology Group, Int. J. Radiat. Oncol. Biol. Phys. 7, 991-998 (1981).
6. Hornback, N. B., Shupe, R. E., Shidnia, H., Marshall, C. V., and Lauer, T. Advanced stage 3B cancer of the cervix treatment by hyperthermia and radiation, Gynecol. Oncol. 23, 160-167 (1986).
7. Maor, M. H., Gillespie, B. W., Peters, L. J., Wambersie, A., Griffin, T. W., Thomas, F. J., Cohen, L., Conner, N., and Gardner, P. Neutron therapy in cervical cancer: Results of a phase III RTOG study, Int. J. Radiat. Oncol. Biol. Phys. 14, 885-891 (1988).
8. Dische, S., Anderson, P., and Sealy, R. Carcinoma of the cervix: Anemia, radiotherapy and hyperbaric oxygen, Br. J. Radiol. 56, 251-255 (1986).
9. Wilbanks, G. D., Heaton, D., Yordan, E. A., Reddy, S., Lincoln, S., Bonomi, P., Lee, M., Graham, J., Dolan, T., Phillips, A., Kirschner, C., Bergen, S., and DeGeest, K. Treatment of patients with advanced pelvic malignancies with simultaneous cisplatin, 5-FU and split-course hyperfractionated radiation therapy, Eur. J. Gynaecol. Oncol. 12, 228-229 (1991).
10. Hreshchyshyn, M. M., Aron, B. S., Boronow, R. C., et al. Hydroxyurea or placebo combined with radiation to treat stages IIIB and IV cervical cancer confined to the pelvis, Int. J. Radiat. Oncol. Phys. 5, 317-322 (1979).
11. Piver, M. S., Barlow, J. J., Vongtama, V., et al. Hydroxyurea: A radiation potentiator in carcinoma of the uterine cervix: a randomized double-blind study, Am. J. Obstet. Gynecol. 147, 803-808 (1983).
12. Stehman, F. B., Bundy, B. N., Thomas, G., Keys, H. M., d'Ablaing, G., Fowler, W. C., Mortel, R., and Creasman, W. T. Hydroxyurea versus misonidazole with radiation in cervical carcinoma: Long-term follow-up of a gynecologic oncology group trial, J. Clin. Oncol. 11, 1523-1528 (1993).
13. Thigpen, T., Shingleton, H., Homesley, H., Lagasse, L., and Blessing, J. cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: A phase II study of the Gynecologic Oncology Group, Cancer 48, 899-903 (1981).
14. Alberts, D. S., Garcia, D., and Mason-Liddil, N. Cisplatin in advanced cancer of the cervix: An update, Semin. Oncol. 18, 11-24 (1991).
15. Couglin, C. T., and Richmond, R. C. Biological and clinical developments of cisplatin combined with radiotherapy: Concepts, utility, projections for new trials, and the emergence of carboplatin, Semin. Oncol. 16(4 Suppl. 6), 31-43 (1989).
16. Fu, K. K., Lam, K. N., and Rayner, P. A. The influence of time sequence of cisplatin administration and continuous low dose rate irradiation (CLDRI) on their combined effects on a murine squamous cell carcinoma, Int. J. Radiat. Oncol. Biol. Phys. 11, 2119-2124 (1985).
17. Dewit, L. Combined treatment of radiation and cis-diamminedichloroplatinum(II): A review of experimental and clinical data, Int. J. Radiat. Biol. Phys. 13, 403-426 (1987).
18. Douple, E. B. Keynote address: Platinum-radiation interactions, NCI Monogr. 6, 315-319 (1988).
19. Malfetano, J. H., and Keys, H. Aggressive multimodality treatment for cervical cancer with paraaortic lymph node metastases, Gynecol. Oncol. 42, 44-47 (1991).
20. Roberts, W. S., Hoffman, M. S., Kavanagh, J. J., Fiorica, J. V., Greenberg, H., Finan, M. A., and Cavanagh, D. Further experience with radiation therapy and concomitant intravenous chemotherapy in advanced carcinoma of the lower genital tract, Gynecol. Oncol. 43, 233-236 (1991).
21. Pearcey, R. G., Stuart, G. C. E., MacLean, G. D., Nation, J. G., Arthur, K., Lukka, H., Jeffrey, J., James, K., and Brundage, M. Phase II study to evaluate the toxicity and efficacy of concurrent cisplatin and radiation therapy in the treatment of patients with locally advanced squamous cell carcinoma of the cervix, Gynecol. Oncol. 58, 34-41 (1995).
22. Malfetano, J., Keys, H., Kredentser, D., Cunningham, M., Kotlove, D., and Weiss, L. Weekly cisplatin and radical radiation therapy for advanced, recurrent, and poor prognosis cervical carcinoma, Cancer 71, 3703-3706 (1993).
23. Wong, L. C., Choo, Y. C., Choy, D., Sham, J. S. T., and Ma, H. K. Long-term follow-up of potentiation of radiotherapy by cis-platinum in advanced cervical cancer, Gynecol. Oncol. 35, 159-163 (1989).
24. Stehman, F. B., and Bundy, B. N. Carcinoma of the cervix treated with chemotherapy and radiation therapy, Cancer 71, 1697-1701 (1993).
25. Rose, R. G. Locally advanced cervical carcinoma: The role of chemoradiation, Semin. Oncol. 21, 47-53 (1994).
26. Rotman, M. Z. Chemoirradiation: A new initiative in cancer treatment: 1991 RSNA annual oration in radiation oncology, Radiology 184, 319-327 (1992).
27. Choo, Y. C., Choy, T. K., Wong, L. C., and Ma, H. K. Potentiation of radiotherapy by cis-dichlorodiammineplatinum(II) in advanced cervical carcinoma, Gynecol. Oncol. 23, 94-100 (1986).
28. Pearcey, R. G., and MacLean, G. D. A phase I/II study combining radical radiotherapy with concurrent cisplatin in the treatment of advanced squamous cell carcinoma of the cervix, J. Gynecol. Cancer 2, 215-219 (1992).
29. Runowicz, C. D., Wadler, S., Rodriguez-Rodriguez, L., Litwin, P., Shaves, M., O'Hanlan, K. A., Goldberg, G. L., Tomaino, C. T., and Byrnes, R. Concomitant cisplatin and radiotherapy in locally advanced cervical carcinoma, Gynecol. Oncol. 34, 395-401 (1989).
30. Runowicz, C. D., Smith, H. O., and Goldberg, G. L. Multimodality therapy in locally advanced cervical cancer, Curr. Opin. Obstet. Gynecol. 5, 92-98 (1993).
31. Park, T. K., Lee, S. K., Kim, S. N., Hwang, T. S., Kim, G. E., Suh, C. O., and Loh, J. K. Combined chemotherapy and radiation for bulky stages I-II cervical cancer: Comparison of concurrent and sequential regimens, Gynecol. Oncol. 50, 196-201 (1993).
32. Souhami, I., Gil, R. A., Allan, S. E., Canary, P. C. V., Aravjo, C. M. M., Pinto, L. H. J., and Silveira, T. R. P. A randomized trial of chemotherapy followed by pelvic radiation therapy, J. Clin. Oncol. 9, 970-977 (1991).
33. Vermorken, J. B. Neoadjuvant chemotherapy in cervical cancer still promising? (Editorial), Ann. Oncol. 3, 97-101 (1992).
34. Patton, T. J., Kavanagh, J. J., Delclos, L., Wallace, S., Haynie, T. P., Gershenson, D. M., Wharton, J. T., and Bass, S. Five-year survival in patients given intra-arterial chemotherapy prior to radiotherapy for advanced squamous carcinoma of the cervix and vagina, Gynecol. Oncol. 42, 54-59 (1991).
35. Thoms, W. W., Eifel, P. J., Smith, T. L., Morris, M., Delclos, L., Wharton, J. T., and Oswalk, M. J. Bulky endocervical carcinoma: A 23-year experience, Int. J. Radiat. Oncol. Biol. Phys. 23, 491-499 (1992).
36. Gallion, H. H., van Nagell, J. R., Donaldson, E. S., Hanson, M. B., Powell, D. E., Maruyama, Y., and Yoneda, J. Combined radiation therapy and extrafascial hysterectomy in the treatment of Stage IB barrel-shaped cervical cancer, Cancer 56, 262-265 (1985).
37. Chung, C. K., Nahhas, W. A., Stryker, J. A., Curry, S. L., Abt, A. B., and Mortel, R. Analysis of factors contributing to treatment failures in Stages IB and IIA carcinoma of the cervix, Am. J. Obstet. Gynecol. 138, 550-556 (1980).
38. Delgado, G., Bundy, B., Zaino, R., Sevin, B. U., Creasman, W. T., and Major, F. Prospective surgical-pathological study of disease-free interval in patients with Stage IB squamous cell carcinoma of the cervix: A gynecologic oncology group study, Gynecol. Oncol. 38, 352-357 (1990).
39. Rotman, M., Pajak, T. F., Choi, K., Clery, M., Marcial, V., Grigsby, P. W., Cooper, J., and John, M. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas: Ten-year treatment results of RTOG 79-20, J. Am. Med. Assoc. 274(5), 387-393 (1995).
40. Thomas, G., Dembo, A., Fyles, A., Gadalla, T., Beale, F., Bean, H., Pringle, J., Rawlings, G., Bush, R., and Black, B. Concurrent chemoradiation in advanced cervical cancer, Gynecol. Oncol. 38, 446-451 (1990).
41. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observations, J. Am. Stat. Assoc. 53, 457-481 (1958).
42. Wilcoxon, F. Individual comparisons by ranking methods, Biometrics 1, 80-83 (1945).